Liprostin Group, Inc.

Our patented, drug delivery system, Liprostin, encapsulates Prostaglandin 1 in a liposome which can treat deadly COVID-19 Lung inflammation and cytokine storms.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Houston, TX, USA
  • Currency USD
  • Founded February 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website LiprostinGroup.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free